| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 762OS3ZEJU |
Structure
| InChI Key | BNQDCRGUHNALGH-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C10H15N3O5 |
| Molecular Weight | 257.25 |
| AlogP | -1.76 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 7.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 148.07 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 18.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
|
- | 2400 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Parkinson Disease | 3 | D010300 | ClinicalTrials |
| Restless Legs Syndrome | 3 | D012148 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 322-35-0 |
| ChEBI | 64187 |
| ChEMBL | CHEMBL1096979 |
| DrugBank | DB12783 |
| DrugCentral | 314 |
| EPA CompTox | DTXSID9022651 |
| FDA SRS | 762OS3ZEJU |
| Guide to Pharmacology | 5150 |
| PharmGKB | PA165360203 |
| PubChem | 2327 |
| SureChEMBL | SCHEMBL34522 |
CONTENTS